![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Long-Acting Biodegradable Subcutaneous Implant for
Tenofovir Alafenamide Fumarate HIV PrEP
|
|
|
CROI 2016
Reported by Jules Levin
Erica Schlesinger1, Daniel Johengen1, Leah Johnson3, Stephanie Swarner3, Ginger Rothrock3 , Ian McGowan4, Ariane van der Straten2, Tejal Desai1
1. Joint Graduate Group in Bioengineering, University of California Berkeley – University of California San Francisco
2. Women’s Global Health Imperative, RTI International, San Francisco; 3. RTI International, RTP; 4. Magee Women’s Research Institute and Foundation/University of Pittsburgh
Pharmacokinetics of Long-acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis http://www.natap.org/2016/HIV/021116_01.htm
![1save](../../2017/images/013117/013117-3/1save.gif)
![0131172](../../2017/images/013117/013117-3/0131172.gif)
![0131173](../../2017/images/013117/013117-3/0131173.gif)
![0131174](../../2017/images/013117/013117-3/0131174.gif)
![0131175](../../2017/images/013117/013117-3/0131175.gif)
![0131176](../../2017/images/013117/013117-3/0131176.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|